These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35083638)

  • 1. A meta-analysis of combination therapy with gonadotrophin-releasing hormone agonist and growth hormone for children with idiopathic short stature and normal timed puberty.
    Zhou B; Liu S; Wang J; Zhang T; Yuan Y; Niu W; Zhang Z; Wang L
    Endocrine; 2022 Mar; 75(3):698-708. PubMed ID: 35083638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Final height after combined growth hormone and gonadotrophin-releasing hormone analogue therapy in short healthy children entering into normally timed puberty.
    Lanes R; Gunczler P
    Clin Endocrinol (Oxf); 1998 Aug; 49(2):197-202. PubMed ID: 9828907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult height in short normal girls treated with gonadotropin-releasing hormone analogs and growth hormone.
    Pasquino AM; Pucarelli I; Roggini M; Segni M
    J Clin Endocrinol Metab; 2000 Feb; 85(2):619-22. PubMed ID: 10690865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Beneficial Effect of Combined GH/GnRHa Therapy in Increasing Adult Height Outcome in Children With ISS.
    Lazar L; Levy S; Oron T; Meyerovitch J; de Vries L; Shalitin S; Tenenbaum A; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2019 Aug; 104(8):3287-3295. PubMed ID: 30912806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined therapy with GnRH analogue and growth hormone increases adult height in children with short stature and normal pubertal onset.
    Li S; Wang X; Zhao Y; Ji W; Mao J; Nie M; Wu X
    Endocrine; 2020 Sep; 69(3):615-624. PubMed ID: 32533506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.
    Li P; Li Y; Yang CL
    Medicine (Baltimore); 2014 Dec; 93(27):e260. PubMed ID: 25501098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation.
    Kamp GA; Mul D; Waelkens JJ; Jansen M; Delemarre-van de Waal HA; Verhoeven-Wind L; Frölich M; Oostdijk W; Wit JM
    J Clin Endocrinol Metab; 2001 Jul; 86(7):2969-75. PubMed ID: 11443153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of different therapy regimens to increase final adult height in males at advanced bone age with idiopathic short stature.
    Wang W; Wang Y; Xiao Y; Cao N; Wang Y
    BMC Pediatr; 2023 Dec; 23(1):615. PubMed ID: 38053091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined use of growth hormone and gonadotropin-releasing hormone analogues: the national cooperative growth study experience.
    Kohn B; Julius JR; Blethen SL
    Pediatrics; 1999 Oct; 104(4 Pt 2):1014-8. PubMed ID: 10506254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Gonadotropin-Releasing Hormone Analogue on Final Adult Height in Children with Idiopathic Short Stature.
    Khawaja N; Owaineh H; Batieha A; Frahid O; El-Khateeb M; Ajlouni KM
    Med Princ Pract; 2019; 28(6):509-516. PubMed ID: 30995651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the growth outcome of children with idiopathic short stature and isolated growth hormone deficiency following treatment with growth hormone and a luteinizing hormone-releasing hormone agonist superior to that obtained by GH alone?
    Colmenares A; González L; Gunczler P; Lanes R
    J Pediatr Endocrinol Metab; 2012; 25(7-8):651-7. PubMed ID: 23155689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should Skeletal Maturation Be Manipulated for Extra Height Gain?
    Wit JM
    Front Endocrinol (Lausanne); 2021; 12():812196. PubMed ID: 34975773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of gonadotropin-releasing hormone agonist monotherapy and combination therapy with growth hormone on final adult height in girls with central precocious puberty.
    Cho AY; Shim YS; Lee HS; Hwang JS
    Sci Rep; 2023 Jan; 13(1):1264. PubMed ID: 36690835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM; Boersma B; de Muinck Keizer-Schrama SM; Nienhuis HE; Oostdijk W; Otten BJ; Delemarre-Van de Waal HA; Reeser M; Waelkens JJ; Rikken B
    Clin Endocrinol (Oxf); 1995 Apr; 42(4):365-72. PubMed ID: 7750190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is a Combination of a GnRH Agonist and Recombinant Growth Hormone an Effective Treatment to Increase the Final Adult Height of Girls with Precocious or Early Puberty?
    Song W; Zhao F; Liang S; Li G; Xue J
    Int J Endocrinol; 2018; 2018():1708650. PubMed ID: 30693027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of gonadotropin-releasing hormone analog combined with stanazolol on final height in girls with idiopathic central precocious puberty and apparent decrease of linear growth].
    Li YH; Zhu SY; Ma HM; Su Z; Chen HS; Chen QL; Gu YF; Du ML
    Zhonghua Er Ke Za Zhi; 2013 Nov; 51(11):807-12. PubMed ID: 24484553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of a 4-year combination therapy of growth hormone and gonadotropin-releasing hormone analogue in pubertal girls with short predicted adult height.
    Dotremont H; France A; Heinrichs C; Tenoutasse S; Brachet C; Cools M; De Waele K; Massa G; Lebrethon MC; Gies I; Van Besien J; Derycke C; Ziraldo M; De Schepper J; Beauloye V; Verhulst S; Rooman R; den Brinker M
    Front Endocrinol (Lausanne); 2023; 14():1113750. PubMed ID: 37008942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dose-dependent effect of growth hormone on final height in children with short stature without growth hormone deficiency.
    Albertsson-Wikland K; Aronson AS; Gustafsson J; Hagenäs L; Ivarsson SA; Jonsson B; Kriström B; Marcus C; Nilsson KO; Ritzén EM; Tuvemo T; Westphal O; Aman J
    J Clin Endocrinol Metab; 2008 Nov; 93(11):4342-50. PubMed ID: 18728172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
    Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
    J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative calcaneal ultrasound parameters and bone mineral density at final height in girls treated with depot gonadotrophin-releasing hormone agonist for central precocious puberty or idiopathic short stature.
    Kapteijns-van Kordelaar S; Noordam K; Otten B; van den Bergh J
    Eur J Pediatr; 2003 Nov; 162(11):776-80. PubMed ID: 13680381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.